← All stocks

Tempest Therapeutics, Inc.

TPST Net buying
CIK 0001544227 #5119 in the set updated 17 Sep 2026
Bought (120 mo)
$6.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$967.03K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$967.03K
2 of 2 sales
Net
+$5.15M
+$5.15M against sales at will

By person

18 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Woiwode Thomas
Director
$5.00M (1)
+$5.00M
4,295,055
$9.28M
Angel Matthew
CEO and President
$1.00M (2)
+$1.00M
231,482
$500.00K
Versant Venture Capital VI, L.P. entity
10% owner
$967.03K (2)
−$967.03K
209,941
$453.47K
−79.0%
Brady Stephen R
President and CEO
$73.85K (1)
+$73.85K
46,376
$100.17K
+307.7%
Whiting Samuel
Chief Medical Officer
$18.12K (2)
+$18.12K
9,573
$20.68K
+219.1%
Trojanowski Justin
Corporate Controller
$16.20K (1)
+$16.20K
22,168
$47.88K
+51.1%
Dubensky Thomas W.
President
$9.56K (1)
+$9.56K
113,343
$244.82K
Xu Stella
Director
579,710
$1.25M
ALDRICH RICHARD
Director
312,333
$674.64K
+32.2%
Malley Thomas
Director
204,981
$442.76K
+14.2%
Owens Julia C.
Executive Chair
74,400
$160.70K
Couturier Christophe
Chief Financial Officer
50,900
$109.94K
+0.6%
Gallagher Carol Giltner
Director
31,933
$68.98K
WHITCOMB RANDALL W
Director
15,784
$34.09K
KOZIN MARC D
Director
7,740
$16.72K
Mohideen Pharis
Chief Medical Officer
7,440
$16.07K
FISHER MARY
Director
3,319
$7.17K
Lorenzo Pierre
Corporate Controller
53
$114.48

No percentages here. This company's share count has moved by a factor of 10.2 over the window, from 4,440,161 to 45,483,384 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Angel Matthew
24 Mar 2026
CEO and President
Buy indirect
231,482
$2.16
$500.00K
Angel Matthew
24 Mar 2026
CEO and President
Buy indirect
231,482
$2.16
$500.00K
Versant Venture Capital VI, L.P.
12 Aug 2024
10% owner
Sell
387,999
$1.10
$426.99K
Versant Venture Capital VI, L.P.
8 Aug 2024
10% owner
Sell
400,000
$1.35
$540.04K
Brady Stephen R
3 Jul 2024
President and CEO
Buy
35,000
$2.11
$73.85K
Whiting Samuel
2 Jul 2024
Chief Medical Officer
Buy
4,672
$2.13
$9.95K
Trojanowski Justin
28 Jun 2024
Corporate Controller
Buy
7,500
$2.16
$16.20K
Woiwode Thomas
29 Apr 2022
Director
Buy indirect
2,118,644
$2.36
$5.00M
Dubensky Thomas W.
7 Jan 2022
President
Buy
2,000
$4.78
$9.56K
Whiting Samuel
6 Jan 2022
Chief Medical Officer
Buy
1,700
$4.80
$8.17K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 5,215,748
History held since 12 Sep 2016